Generation Bio, Vir partner for mAbs against COVID-9
March 30, 2020 -- Generation Bio and Vir Biotechnology have agreed to collaborate on research into the use of monoclonal antibodies against the SARS-CoV-2 virus that causes COVID-19.
J&J seeks to release COVID-19 vaccine by 2021
March 30, 2020 -- Johnson & Johnson has selected a lead COVID-19 vaccine candidate from a number of options it has been working on since January. The company hopes to release a vaccine by 2021.
Atum gives labs free access to protein production platform
March 27, 2020 -- Atum has granted commercial and academic laboratories free access to its Leap-In Transposase protein production platform for use in creating tools and resources to battle the COVID-19 pandemic.
Xencor, Vir partner on COVID-19 antibodies research
March 27, 2020 -- Biopharmaceutical companies Xencor and Vir Biotechnology have entered into a technology licensing agreement to develop potential antibody-based treatments for patients with COVID-19.
Vycellix, Avectas partner for product development
March 26, 2020 -- Vycellix and Avectas have unveiled plans to collaborate on the development of cell-based immunotherapeutic products.
Dynavax, Clover partner for protein-based COVID-19 vaccine
March 25, 2020 -- A new research collaboration between Dynavax Technologies and Clover Biopharmaceuticals aims to develop a vaccine candidate to prevent COVID-19. The partnership, announced on March 24, will advance Clover's vaccine candidate, COVID-19 S-Trimer, with Dynavax providing its technical expertise and CpG 1018, a proprietary toll-like receptor 9 agonist adjuvant.
FTC greenlights $20B GE-Danaher deal
March 20, 2020 -- Following an agreement with the U.S. Federal Trade Commission (FTC), GE Healthcare Life Sciences is moving forward with the sale of its GE Biopharma business to Danaher for $20 billion as planned.
NIH shifts noncritical research to maintenance
March 20, 2020 -- The National Institutes of Health (NIH) has decided to shift all laboratory operations that are not mission critical to a maintenance phase, according to a statement released on March 20.
Exothera offers process development, viral vector support to biomanufacturers
March 19, 2020 -- Biomanufacturing company Univercells announced on March 19 that it has established a contract development and manufacturing organization named Exothera to support cell and gene therapy developers with process development and production of viral vectors.
Sengenics offers COVID-19 antigens for vaccine development
March 13, 2020 -- Sengenics announced that it has COVID-19 antigens available for both research and commercial vaccine development purposes for sale.
Conferences
Microbiology Society Annual Conference 2020
March 30 - April 3
Edinburgh, Edinburgh, City of United Kingdom
Experimental Biology 2020
April 4
San Diego, California United States
BioProcess International Europe
April 28 - May 1
Amsterdam, Noord-Holland Netherlands
Lab of the Future USA
May 19-20
Boston, Massachusetts United States
2nd Annual Cell Therapy Bioprocessing Conference
June 25-26
Boston, Massachusetts United States
General Discussion
Topic Replies / Views Last Update
Open science for the modern scientific community
by LMoraes
3 / 51 More than 3 days ago
by The Mets
https://academic.oup.com/ve/pages/coronavirus-evolution
by Michael
0 / 14 More than 3 days ago
by Michael
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
by Mahesh Gupta
0 / 8 More than 3 days ago
by Mahesh Gupta
Engineered Bacteria Produces BeeFree Honey
by Mahesh Gupta
0 / 11 More than 3 days ago
by Mahesh Gupta
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
by Mahesh Gupta
0 / 14 More than 3 days ago
by Mahesh Gupta
To see more posts from our community or to share a post of your own, go to our community's forum page.
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter